Specialty pharmacy has reached an “inflection point” with the power to change the entire industry model.
Both pharmacy groups state that rule should have addressed DIR fees.
Xellia Pharmaceuticals will manufacture essential antibiotics for Civica Rx.
Suit filed in Connecticut alleges companies conspired to inflate prices on more than 100 generic drugs.
New indication joins a series of single-agent and combination treatments for various cancers.
The company is donating enough drugs for 200,000 patients for up to 11 years, but does it make up for the high price of the drug?
Finalized rule is a step toward increasing drug pricing transparency.
Premier is exiting the specialty pharmacy market and selling its ProCare Pharmacy company.
Nearly 12 million pounds of medications collected since the initiative’s inception.
Recent trial shows greater invasive disease-free survival when treated with Kadcyla , (ado-trastuzumab emtansine)